|
ADRBK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81759999995368E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53280000000566E-05 |
| Normal-vs-Stage2 |
6.818200E-03 |
| Normal-vs-Stage3 |
8.996000E-04 |
| Normal-vs-Stage4 |
7.448800E-04 |
| Stage1-vs-Stage2 |
8.690800E-01 |
| Stage1-vs-Stage3 |
8.329000E-01 |
| Stage1-vs-Stage4 |
4.506000E-01 |
| Stage2-vs-Stage3 |
7.785000E-01 |
| Stage2-vs-Stage4 |
6.643800E-01 |
| Stage3-vs-Stage4 |
4.100200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89770000000611E-07 |
| Normal-vs-AfricanAmerican |
6.697000E-01 |
| Normal-vs-Asian |
8.224400E-02 |
| Caucasian-vs-AfricanAmerican |
4.321000E-03 |
| Caucasian-vs-Asian |
4.040400E-01 |
| AfricanAmerican-vs-Asian |
7.162000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14389999994469E-06 |
| Normal-vs-Female |
5.169300E-04 |
| Male-vs-Female |
2.502000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.495600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.61057999999992E-05 |
| Normal-vs-Age(61-80Yrs) |
1.69862999999104E-05 |
| Normal-vs-Age(81-100Yrs) |
2.347800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.129000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.965200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.698000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.397400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.245000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.459200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.653220E-01 |
| Normal-vs-Grade 2 |
5.89329999999277E-05 |
| Normal-vs-Grade 3 |
1.76007000000089E-05 |
| Normal-vs-Grade 4 |
1.577190E-03 |
| Grade 1-vs-Grade 2 |
6.157600E-01 |
| Grade 1-vs-Grade 3 |
5.069000E-01 |
| Grade 1-vs-Grade 4 |
4.851400E-01 |
| Grade 2-vs-Grade 3 |
6.090600E-01 |
| Grade 2-vs-Grade 4 |
4.679000E-01 |
| Grade 3-vs-Grade 4 |
6.747400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.024300E-04 |
| Normal-vs-ccB subtype |
5.075700000301E-07 |
| ccA subtype-vs-ccB subtype |
8.338200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36610000037274E-07 |
| Normal-vs-N1 |
6.964200E-02 |
| N0-vs-N1 |
4.103800E-01 |
|
|
